[ET Net News Agency, 2 November 2022] ALI HEALTH (00241) rose 2.75% to HK$3.74.
It hits an intra-day high of HK$3.75, and an intra-day low of HK$3.57. The total shares
traded was 18.29 million, with a value of HK$67.09m. The active buy/sell ratio is 58:42,
with net buying turnover of HK$10.79m. MACQUARIE CAPITAL accounts for greatest net
responsive buying turnover of HK$2.76m, with volume weighted average price of HK$3.678.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of
HK$3.63m, with volume weighted average price of HK$3.665. The stock has risen a combined
12.65% over the past 2 consecutive trading days.
The Hang Seng Index now rose 15 points, or 0.1% to 15,470; the Hang Seng China
Enterprises Index now rose 3 points, or 0.06% to 5,212; the Hang Seng TECH Index now fell
18 points, or 0.61% to 3,056; with an overall turnover of HK$42.49b.
The SSE Composite Index now rose 15 points, or 0.51% to 2,984, with an overall turnover
of RMB199.24b.
The SZSE Component Index now rose 81 points, or 0.76% to 10,815, with an overall
turnover of RMB119.33b.

Basic Information
=================

----------------------------------
Nominal 3.740 % Chg +2.75%
High 3.750 Low 3.570
Shares Tr 18.29m Turnover 67.09m
10-D SMA 3.471 %H.V 101.472
20-D SMA 3.498 VWAP 3.668
50-D SMA 3.879 RSI14 53.091
----------------------------------
Status: Active buy/sell ratio is 58:42, with net buying turnover of HK$10.79m, rising a
combined 12.65% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALI HEALTH (00241) 3.74 +2.75
TRAD CHI MED (00570) 3.73 +2.47
SINOPHARM (01099) 15.20 -0.26
SINO BIOPHARM (01177) 4.32 +3.10
INNOVENT BIO (01801) 28.55 +3.44
FOSUN PHARMA (02196) 23.70 +9.98
WUXI BIO (02269) 38.45 +1.32
CANSINOBIO (06185) 126.00 +46.00
JD HEALTH (06618) 48.85 +4.83
AKESO-B (09926) 31.80 +2.25
---------------------------------------------
(ed)